Study ID: CGX-635-CML-202 | 2006-000176-32
Study Title
- Homoharringtonine (Omacetaxine Mepesuccinate) in Treating Patients With Chronic Myeloid Leukemia (CML) With the T315I BCR-ABL Gene Mutation
Teva Identifier
- CGX-635-CML-202 | 2006-000176-32
ClinicalTrials.gov Identifier
- NCT00375219
Study Status
- Completed
Trial Condition(s)
- Chronic Myeloid Leukemia
Interventions
- Drug: Omacetaxine mepesuccinate
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years and older
Trial Duration
- 09/01/2006 - 09/01/2013
Phase
- Phase 2
Study Type
Interventional
